INFINITY PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

55 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter between the Registrant and Robert Ilaria, Jr., M.D., dated August 11, 2021
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2021
Offer Letter between the Registrant and Stephane Peluso, Ph.D., dated July 12, 2021
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2021
Description of Securities Registered Under Section 12 of the Exchange Act
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2021
Description of Securities Registered Under Section 12 of the Exchange Act
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2020
Offer Letter between the Registrant and Samuel Agresta, M.D., dated July 19, 2018
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2018
THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2017
THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2017
THIS IS AN IMPORTANT LEGAL DOCUMENT. PLEASE CONFER WITH A LAWYER OR OTHER TRUSTED ADVISOR BEFORE SIGNING THIS DOCUMENT.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2017
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2016
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2010
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisksdenote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2009
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisksdenote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
NY
2009
INFINITY PHARMACEUTICALS, INC. SECOND AMENDMENT TO RIGHTS AGREEMENT
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2008
INFINITY PHARMACEUTICALS, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2008
AMENDMENT NO. 4 TO INFINITY PHARMACEUTICALS, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2007
AMENDMENT NO. 1 TO DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
DE
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
DE
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
DE
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
MA
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
Date of
INFINITY PHARMACEUTICALS, INC.
Biotechnology
DE
2006
Page 2
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
MA
2006
Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Asterisks denote omissions.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
CA
2006
INFINITY PHARMACEUTICALS, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2006
ASSETPURCHASE AGREEMENT between: DiscoveryPartners International, INC., aDelaware corporation; and IRORIDISCOVERY, INC., aCalifornia corporation Effectiveas of October 7, 2005
INFINITY PHARMACEUTICALS, INC.
Biotechnology
CA
2006
DISCOVERY PARTNERS INTERNATIONAL,INC. STOCKISSUANCE AGREEMENT UNDER THE 2000 STOCKINCENTIVE PLAN
INFINITY PHARMACEUTICALS, INC.
Biotechnology
CA
2005
SEPARATIONAGREEMENT
INFINITY PHARMACEUTICALS, INC.
Biotechnology
CA
2005
FY Base Periods 1-5 Estimated Costs Option 04 Fixed Fee Estimated Cost Plus Fixed Fee 04 Period 1 (8/23/04 -12/23/04) [***] $ [***] [***] [***] 05 Period 2 (12/24/04-12/23/05)...
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2004
PRICING SCHEDULE
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2004
CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2003
CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2003
CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2003
CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2003
CHANGE-IN-CONTROLAGREEMENT FOR CERTAIN EXECUTIVES OF DISCOVERY PARTNERS INTERNATIONAL, INC.
INFINITY PHARMACEUTICALS, INC.
Biotechnology
2003